MedLea Srls

Medlea is expanding and we are looking for partners in Portugal. At Medlea, we are at the forefront of digital medicine, developing innovative solutions that leverage digital twins and AI-driven diagnostics to improve lung health management and surgical planning. As part of our growth strategy, we are seeking a strategic partner to support us in opening a subsidiary in Portugal. Our goal is to foster collaborations with local healthcare institutions, and contribute to the cutting-edge field of digital healthcare technologies. We are particularly interested in partnering with individuals that have experience in digital health, medical devices, or healthcare innovation. Ideal partners would also have expertise in market access in Portugal and the EU, along with innovation hubs. We are open to working together to adapt and localize our existing products for the Portuguese market. If you are interested in partnering with us or know of an organization that could be a great fit, we would love to hear from you. Please feel free to reach out directly or connect with us to discuss this opportunity.

Did you know that Medlea technology enables the study of diverse biomedical applications? A recent study sheds light on how fluid flow impacts brain clearance mechanisms, crucial for removing byproducts like amyloid proteins linked to Alzheimer’s disease. The research focuses on the interstitial brain space (ISS) and cerebrospinal fluid (CSF), showing that particle transport in the ISS is mostly diffusive under normal conditions. However, CSF’s peristaltic pumping plays a key role in clearance. The study also highlights risks of high shear rates from Convection-Enhanced Delivery (CED) techniques, which could destabilize therapeutic antibodies, reducing their efficacy in Alzheimer’s treatments. Thanks to Antonio Iorio, Philippe Derreumaux, Fabio Sterpone and Simone Melchionna for this impactful work! Read more from the PNAS Nexus open access journal : https://lnkd.in/dBdXaY_y

🚀 Excited to announce my participation at the PACT Mid-Atlantic Capital Conference on October 29! 🎉 I’m looking forward to connecting with fellow innovators, investors, and leaders in the healthcare and technology sectors. As Medlea continues to expand its footprint, particularly with our cutting-edge lung surgery simulation platform, we are actively seeking strategic partnerships to drive growth and innovation. This is a fantastic opportunity to showcase our advancements in lung diagnostics and surgical simulation, and I'm eager to explore how we can collaborate to make a real impact in the field. If you’ll be attending, let’s connect! 🤝 #HealthcareInnovation #DigitalHealth #LungSurgery #PACTConference #MedTech #StrategicPartnerships

MedLea Srl has been cooperating with Kiara MedTech in South Africa for the last six months and looks forward to formalising the relationship very soon. Kiara MedTech drives the introduction of medical technology innovation across the continuum of patient care throughout Sub-Saharan Africa to help improve treatments or to enhance the quality of patients’ lives, through exclusive distribution partnerships with unique global medical technologies, such as MedLea. We also look forward to announcing an exciting project focussed on Mine Dust Lung Diseases in the South African mining industry. Watch this space!